GO
Loading...

CEO Interviews

Juno's promising CAR-T immunotherapy  Tue, 13 Jan '15 | 5:15 PM ET

Hans Bishop, Juno Therapeutics co-founder and CEO, discusses promising data for new cancer immunotherapy approaches.

CSX: Low oil good for us  Tue, 13 Jan '15 | 4:30 PM ET

Michael Ward, CSX Corporation CEO, says the huge plunge in oil prices will be good for his business.

Mike Narachi, Orexigen CEO, speaks with CNBC's Meg Tirrell about its obesity drug and program.

Ariad CEO: Expanding Iclusig  Tue, 13 Jan '15 | 1:47 PM ET

Ariad CEO Harvey Berger, tells CNBC's Meg Tirrell commercially the company had a good year and provides insight into its new cancer drug, Iclusig.

Valeant CEO Mike Pearson tells CNBC's Meg Tirrell the company is on a mission to prove allegations against the business model are not true. Pearson says Valeant is unlikely to work with Bill Ackman.

Chimerix tackles Ebola outbreak  Tue, 13 Jan '15 | 11:46 AM ET

Michelle Berrey, Chimerix CEO, discusses the testing of its Ebola drug Brincidofovir in a clinical setting in West Africa, with CNBC's Meg Tirrell.

Instacart CEO: Shop at the stores you love  Tue, 13 Jan '15 | 11:16 AM ET

CNBC's Josh Lipton speaks to Apoorva Mehta, Instacart CEO, about category expansion in the grocery delivery industry and competition in the space.

Cigna's expansion strategy  Tue, 13 Jan '15 | 10:17 AM ET

David Cordani, Cigna president & CEO, weighs in on rival Aetna's wage plan and explains Cigna's growth strategy.

Noodles CEO: Return of the consumer  Tue, 13 Jan '15 | 8:39 AM ET

CNBC's Courtney Reagan, and Kevin Reddy, Noodles & Company CEO & chairman, discuss the return of the consumer to casual dining and growing demand for fresh food.

I am a better person: Sam Waksal  Tue, 13 Jan '15 | 8:36 AM ET

Sam Waksal, former Imclone Systems CEO, reveals how the ImClone scandal has impacted his life.

I'm not running the show: Sam Waksal  Tue, 13 Jan '15 | 8:33 AM ET

CNBC's Meg Tirrell, and Sam Waksal, Kadmon founder & chairman, discusses his role in the company.

Sam Waksal's IPO biotech plans  Tue, 13 Jan '15 | 8:31 AM ET

CNBC's Meg Tirrell, and Sam Waksal, Kadmon founder & chairman, discuss plans to take the biotech company public.

Dunkin putting lid on styrofoam  Tue, 13 Jan '15 | 7:46 AM ET

Nigel Travis, Dunkin' Brands chairman & CEO, discusses a new cup that will come to market that will keep beverages "very hot" and totally recyclable.

Dunkin's on the run: CEO  Tue, 13 Jan '15 | 7:44 AM ET

Nigel Travis, Dunkin' Brands chairman & CEO, discusses Dunkin's franchise expansion plans while providing a convenient experience for consumers.

Steve Kandarian, MetLife chairman & CEO, explains why he thinks his company should not be designated as SIFI.

MetLife suing government over SIFI  Tue, 13 Jan '15 | 7:33 AM ET

Steve Kandarian, MetLife chairman & CEO, says his company is fighting back against the government's assertion the insurance giant is too big to fail and should be designated a "systemically important financial institution."

Terry Lundgren, Macy's chairman & CEO, weighs in on the shopping experience of going into a physical store versus online shopping.

Macy's CEO: Online retail not only answer  Tue, 13 Jan '15 | 7:03 AM ET

Terry Lundgren, Macy's chairman & CEO, discusses the retailer's strategy to invest in technology to enhance the omnichannel retail experience.

Merck CEO: Deals create value  Mon, 12 Jan '15 | 4:27 PM ET

Merck CEO Ken Frazier plans to focus on its specialized area strategy in 2015, with CNCB's Meg Tirrell.

Newly elected to NRF's board of directors, Kip Tindell, The Container Store CEO, discusses trouble with traffic in stores in Q2 and Q3. National Retail Federation CEO Matthew Shay, weighs in.

Biogen Idec beefs up pain pipeline  Mon, 12 Jan '15 | 3:16 PM ET

Dr. George Scangos, Biogen Idec CEO, discusses new therapies in multiple sclerosis, Alzheimer's disease and pain.

Targeting cancer's metabolism  Mon, 12 Jan '15 | 2:46 PM ET

Dr. David Schenkein, Agios CEO, explains a cancer's metabolism, and the company's priorities for 2015.

The consumer is feeling better, but it's not unbridled optimism, explains HSN, Inc. CEO Mindy Grossman. She discusses what contributed to a successful holiday season.

Bluebird's catalysts in 2015  Mon, 12 Jan '15 | 1:44 PM ET

Bluebird Bio CEO Nick Leschly, provides insight to how gene therapy can work to treat blood disorders, and sickle cell anemia.

Car of the year: Volkswagen Golf  Mon, 12 Jan '15 | 1:12 PM ET

CNBC's Phil LeBeau, and Michael Horn, Volkswagen Group of America CEO & President, discuss the success of the Golf, and the demand of SUVs.

Actavis CEO: Good can come from activists  Mon, 12 Jan '15 | 12:38 PM ET

Brent Saunders, Actavis CEO, discusses the deal environment, the process of acquiring Allergan and the good that comes from activist investors.

23andMe partners with big pharma  Mon, 12 Jan '15 | 12:20 PM ET

Anne Wojcicki, co-founder and CEO of genetic-testing startup 23andMe, discusses the new deals with Pfizer and Genentech.

Celgene CEO: Creating a great future  Mon, 12 Jan '15 | 11:45 AM ET

CNBC's Meg Tirrell speaks to Robert Hugin, Celgene chairman & CEO, about the company's ambitious long-term guidance and broad-based drug pipeline.

Ford CEO: F-150 redefines tough  Mon, 12 Jan '15 | 10:45 AM ET

Ford's F-150 won truck of the year honors at the Detroit Auto Show. Mark Fields, Ford Motor CEO, discusses the success of its F-Series and the future of autonomous vehicles.

Low gas pressures Toyota's Prius  Mon, 12 Jan '15 | 9:49 AM ET

Jim Lentz, Toyota North America CEO, unveils a new Tacoma at the Detroit Auto Show and discusses the impact of falling gas prices on Prius sales, with CNBC's Phl LeBeau.

Contact CEO Interviews

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More